The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Radiation from the images causes 5 percent of cancer cases, according to a new study. The doctor who made this grim discovery ...

A healthy 36-year-old non-smoker from the UK, was misdiagnosed with anxiety for months before discovering he had terminal ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus immune checkpoint inhibitors. The first patient with small cell lung cancer ...

researchers delivered 7.7 to 22.3 times more of the drug inside cancer cells, making the treatment up to 23 times more potent than before, according to the study published April 17 in Cell.

This study evaluated more than 43,000 adults ages 40 to 64 who were diagnosed with stage I or II non-small cell lung cancer (NSCLC) between 2010 and 2016. Researchers used a difference-in-differences ...

A groundbreaking study has revealed a significant link between the frequency of chest x-ray referrals from GPs and earlier diagnosis and improved survival rates for lung cancer patients. Research from ...

According to Dr Balai, lung infections like pneumonia and pleurisy can also cause chest pain. These conditions lead to inflammation of lung tissue and accumulation of fluid in alveoli (small lung ...